Reprogramming Somatic Cells to Induced Pluripotent Stem Cells
| Reprogramming Transcription Factors | Cell Type | Species | Reference |
| Oct4, Sox2, c-myc and Klf4 | Embryonic and adult Fibroblasts | Mouse | Takahashi & Yamanaka, 2006 |
| Oct4, Sox2, c-myc and Klf4 | Embryonic and tail tip Fibroblasts | Mouse | Wernig et al, 2007 |
| Oct4, Sox2, c-myc and Klf4 | Embryonic Fibroblasts | Mouse | Okita et al, 2007 |
| Oct4, c-myc, Klf4 | Neural stem cells | Mouse | Duinsbergen et al, 2008 |
| Oct3/4, Sox2, c-myc and Klf4 | Fibroblasts | Mouse | Nakagawa et al, 2008 |
| Oct3/4, Sox2, c-myc and Klf4 | Fibroblasts | Human | Nakagawa et al, 2008 |
| Oct4, Sox2, and Klf4 | Fibroblasts | Mouse | Wernig et al, 2008 |
| Oct4 and Klf4 | Neural stem cells | Mouse | Kim et al, 2008 |
| Oct4 and c-myc | Neural stem cells | Mouse | Kim et al, 2008 |
| Oct4 | Neural stem cells | Mouse | Kim et al, 2009 |
| Oct4, Sox2, c-myc and Klf4 | Fibroblasts | Human | Takahashi et al, 2007 |
| Oct4 and Sox2 | Fibroblasts | Human | Huangfu et al, 2008 |
| Oct4, Sox2, c-myc and Klf4 | Keratinocytes | Human | Aasen et al, 2008 |
| Oct4, Sox2, c-myc and Klf4 Skin | Fibroblasts | Human | Taura et al, 2009 |
| Oct4, Sox2, c-myc and Klf4 | Multiple somatic tissues | Mouse | Wernig et al, 2008 |
| Oct4, c-myc and Klf4 | Neural stem cells | Mouse | Eminli et al, 2008 |
| Oct4, Sox2, c-myc and Klf4 | B lymphocytes | Mouse | Hanna et al, 2008 |
| Oct4, Sox2, c-myc and Klf4 | Embryonic Fibroblasts | Mouse | Okita et al, 2008 |
| Oct4, Sox2, c-myc and Klf4 | Hepatocytes and Fibroblasts | Mouse | Stadtfeld et al. 2008 |
| Oct4, Sox2 and Esrrb | Embryonic Fibroblasts | Mouse | Feng et al, 2009 |
| Oct4 | Keratinocytes | Mouse | Grinnell et al, 2007 |
| Oct4, Sox2, c-myc and Klf4+2A peptides | Fibroblasts | Mouse | Kaji et al, 2009 |
| Oct4, Sox2, c-myc and Klf4+2A peptides | Fibroblasts | Human | Kaji et al, 2009 |
| Oct4, Sox2, c-myc and Klf4 | Keratinocytes | Human | Dimos et al, 2008 |
| Oct4, Sox2, Nanog and lin28 | Fibroblasts | Human | Ebert et al, 2009 |
| Oct4, Sox2, c-myc and Klf4 | Blood cells | Human | Loh et al, 2009 |
Ref
1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol
2008;26(11):1276–1284. [PubMed: 18931654]
2. Agarwal S. Cellular reprogramming. Methods Enzymol 2006;420:265–283. [PubMed: 17161701]
3. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009;15(2):59–68. [PubMed: 19162546]
4. Andrews PW, Goodfellow PN. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells. Somatic Cell Genet 1980;6(2):271–284. [PubMed: 6994266]
5. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003;17(1):126–140. [PubMed: 12514105]
6. Barroca V, Lassalle B, Coureuil M, Louis JP, Le Page F, Testart J, et al. Mouse differentiating spermatogonia can generate germinal stem cells in vivo. Nat Cell Biol 2009;11(2):190–196. [PubMed: 19098901]
7. Ben-Shushan E, Thompson JR, Gudas LJ, Bergman Y. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a
novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 1998;18(4):1866–1878. [PubMed: 9528758]
8. Beyhan Z, Iager AE, Cibelli JB. Interspecies nuclear transfer: implications for embryonic stem cell biology. Cell Stem Cell 2007;1(5):502–512. [PubMed: 18371390]
9. Boiani M, Eckardt S, Scholer HR, McLaughlin KJ. Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev 2002;16(10):1209–1219. [PubMed: 12023300]
10. Brem G, Kuhholzer B. The recent history of somatic cloning in mammals. Cloning Stem Cells 2002;4(1):57–63. [PubMed: 12006157]
11. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 2007;450(7169):497–502. [PubMed: 18004281]
12. Campbell KH, Fisher P, Chen WC, Choi I, Kelly RD, Lee JH, et al. Somatic cell nuclear transfer: Past, present and future perspectives. Theriogenology 2007;68(Suppl 1):S214–231. [PubMed: 17610946]
13. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27(3):275–280. [PubMed: 19252484]
14. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007;211(1):1–9. [PubMed: 17117392]
15. Cowan CA, Atienza J, Melton DA, Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005;309(5739):1369–1373. [PubMed: 16123299]
16. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.Science 2008;321(5893):1218–1221. [PubMed: 18669821]
17. Do JT, Scholer HR. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 2004;22(6):941–949. [PubMed: 15536185]
18. Do JT, Scholer HR. Cell-cell fusion as a means to establish pluripotency. Ernst Schering Res Found Workshop 2006;(60):35–45. [PubMed: 16903415]
19. Duinsbergen D, Eriksson M., t, Hoen PA, Frisen J, Mikkers H. Induced pluripotency with endogenous and inducible genes. Exp Cell Res 2008;314(17):3255–3263. [PubMed: 18656469]
20. Ebert AD, Yu J, Rose FF Jr. Mattis VB, Lorson CL, Thomson JA, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457(7227):277–280. [PubMed: 19098894]
21. Egli D, Rosains J, Birkhoff G, Eggan K. Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 2007;447(7145):679–685. [PubMed: 17554301]
22. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 2004;26(2-4):148–165. [PubMed: 15711057]
23. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008;26(10):2467–2474. [PubMed: 18635867]
24. Feng B, Jiang J, Kraus P, Ng JH, Heng JC, Chan YS, et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009;11(2):197–203. [PubMed: 19136965]
25. Flake AW, Zanjani ED. Cellular therapy. Obstet Gynecol Clin North Am 1997;24(1):159–177. [PubMed: 9086524]
26. Flasza M, Shering AF, Smith K, Andrews PW, Talley P, Johnson PA. Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers. Cloning Stem Cells 2003;5(4):339–354. [PubMed: 14733752]
27. Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 2005;24(9):1491–1500. [PubMed: 15674344]
28. Fulka J Jr. First NL, Loi P, Moor RM. Cloning by somatic cell nuclear transfer. Bioessays 1998;20(10):847–851. [PubMed: 9819572]
29. Fulka J Jr. Loi P, Fulka H, Ptak G, Nagai T. Nucleus transfer in mammals: noninvasive approaches for the preparation of cytoplasts. Trends Biotechnol 2004;22(6):279–283. [PubMed: 15158056]
30. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300(5618):489–492. [PubMed:12702876]
31. Gearhart J, Pashos EE, Prasad MK. Pluripotency redux–advances in stem-cell research. N Engl J Med 2007;357(15):1469–1472. [PubMed: 17928593]
32. Gmur R, Solter D, Knowles BB. Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids. J Exp Med 1980;151(6):1349–1359. [PubMed:7381363]
33. Gonzales C, Pedrazzini T. Progenitor cell therapy for heart disease. Exp Cell Res. 2009
34. Grinnell KL, Yang B, Eckert RL, Bickenbach JR. De-differentiation of mouse interfollicular keratinocytes by the embryonic transcription factor Oct-4. J Invest Dermatol 2007;127(2):372–
380. [PubMed: 16932739]
35. Gurdon JB, Melton DA. Nuclear reprogramming in cells. Science 2008;322(5909):1811–1815.[PubMed: 19095934]
36. Hanna J, Saha K, Pando B, Zon J, Lenger C, Creyghton M. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462:595–601. [PubMed: 19898493]
37. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008;133(2):250–264. [PubMed: 18423197]
38. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318(5858): 1920–1923. [PubMed: 18063756]
39. Heyman Y, Vignon X, Chesne P, Le Bourhis D, Marchal J, Renard JP. Cloning in cattle: from embryo splitting to somatic nuclear transfer. Reprod Nutr Dev 1998;38(6):595–603. [PubMed: 9932293]
40. Hiiragi T, Solter D. Reprogramming is essential in nuclear transfer. Mol Reprod Dev 2005;70(4): 417–421. [PubMed: 15685639]
41. Hochedlinger K, Jaenisch R. Nuclear transplantation: lessons from frogs and mice. Curr Opin Cell Biol 2002;14(6):741–748. [PubMed: 12473349]
42. Hochedlinger K, Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med 2003;349(3):275–286. [PubMed: 12867612]
43. Hochedlinger K, Jaenisch R. Nuclear reprogramming and pluripotency. Nature 2006;441(7097): 1061–1067. [PubMed: 16810240]
44. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009;136(4):509–523. [PubMed: 19168672]
45. Hochedlinger K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R. Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hematol J 2004;5(Suppl 3):S114–117. [PubMed: 15190291]
46. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005;121(3):465–477. [PubMed:
15882627]
47. Hotta A, Ellis J. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J Cell Biochem 2008;105(4):940–948. [PubMed: 18773452]
48. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26(7):795–797. [PubMed: 18568017]
49. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008;26(11):
1269–1275. [PubMed: 18849973]
50. Ichida J, Blanchard J, Lam K, Son E, Chung J, Egli D, et al. A small molecule inhibitor of TGF-beta signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 2009;5:491–
503. [PubMed: 19818703]
51. Jaenisch R, Hochedlinger K, Blelloch R, Yamada Y, Baldwin K, Eggan K. Nuclear cloning, epigenetic reprogramming, and cellular differentiation. Cold Spring Harb Symp Quant Biol 2004;69:19–27. [PubMed: 16117629]
52. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009a;458(7239):771–775. [PubMed: 19252477]
53. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 2009b
54. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009;136(3):411–419. [PubMed: 19203577]
55. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008;454(7204):646–650.
[PubMed: 18594515]
56. Kimura H, Tada M, Nakatsuji N, Tada T. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol Cell Biol 2004;24(13):5710–5720. [PubMed: 15216876]
57. Korsgren O, Nilsson B. Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes. Curr Opin Organ Transplant. 2009
58. Kosaka N, Kodama M, Sasaki H, Yamamoto Y, Takeshita F, Takahama Y, et al. FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation. FASEB J 2006;20(9):1484–1485.
[PubMed: 16723380]
59. Liu SV. iPS cells: a more critical review. Stem Cells Dev 2008;17(3):391–397. [PubMed: 18426340]
60. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood. Blood. 2009
61. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38(4):431–440. [PubMed: 16518401]
62. Lopez Moratalla N. [Ethical principles in research related to regenerative therapy]. Cuad Bioet 2008;19(66):195–210. [PubMed: 18611071]
63. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;3(6):595–605. [PubMed: 19041776]
64. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell
2007;1(1):55–70. [PubMed: 18371336]
65. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007;9(6):625–635. [PubMed: 17515932]
66. Miller RA, Ruddle FH. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 1976;9(1): 45–55. [PubMed: 61820]
67. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26(1):101–106. [PubMed: 18059259]
68. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24(4):372–376. [PubMed: 10742100]
69. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001;19(3):193–204. [PubMed: 11359944]
70. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448(7151):313–317. [PubMed: 17554338]
71. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008;322(5903):949–953. [PubMed: 18845712]
72. Okuda A, Fukushima A, Nishimoto M, Orimo A, Yamagishi T, Nabeshima Y, et al. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J 1998;17(7):2019–2032. [PubMed: 9524124]
73. Ovitt CE, Scholer HR. The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod 1998;4(11):1021–1031. [PubMed: 9835353]
74. Pan G, Li J, Zhou Y, Zheng H, Pei D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J 2006;20(10):1730–1732. [PubMed: 16790525]
75. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell 2008;134(5):877–886. [PubMed: 18691744]
76. Pera MF, Reubinoff B, Trounson A. Human embryonic stem cells. J Cell Sci 2000;113(Pt 1):5–10. [PubMed: 10591620]
77. Qin D, Gan Y, Shao K, Wang H, Li W, Wang T, et al. Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming with exogenous factors. J Biol Chem 2008;283(48):33730–33735. [PubMed: 18826945]
78. Rao M, Condic ML. Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma. Stem Cells Dev 2008;17(1):1–10. [PubMed: 18271697]
79. Renard JP. Chromatin remodelling and nuclear reprogramming at the onset of embryonic development in mammals. Reprod Fertil Dev 1998;10(7-8):573–580. [PubMed: 10612463]
80. Rhind SM, Taylor JE, De Sousa PA, King TJ, McGarry M, Wilmut I. Human cloning: can it be made safe? Nat Rev Genet 2003;4(11):855–864. [PubMed: 14634633]
81. Rideout WM 3rd, Eggan K, Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science 2001;293(5532):1093–1098. [PubMed: 11498580]
82. Shevchenko AI, Medvedev SP, Mazurok NA, Zakiian SM. [Induced pluripotent stem cells]. Genetika 2009;45(2):160–168. [PubMed: 19334609]
83. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136(5):964–
977. [PubMed: 19269371]
84. Solter D. Mammalian cloning: advances and limitations. Nat Rev Genet 2000;1(3):199–207. [PubMed: 11252749]
85. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008;322(5903):945–949. [PubMed: 18818365]
86. Strong M, Farrugia A, Rebulla P. Stem cell and cellular therapy developments. Biologicals 2009;37(2):103–107. [PubMed: 19231235]
87. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H. Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene 2007;26(38):5564–5576. [PubMed: 17369859]
88. Surani MA. Nuclear reprogramming by human embryonic stem cells. Cell 2005;122(5):653–654. [PubMed: 16143098]
89. Tada M, Tada T, Lefebvre L, Barton SC, Surani MA. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 1997;16(21):6510–6520. [PubMed: 9351832]
90. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001;11(19):1553–1558. [PubMed: 11591326]
91. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131(5):861–872. [PubMed: 18035408]
92. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663–676. [PubMed: 16904174]
93. Taranger CK, Noer A, Sorensen AL, Hakelien AM, Boquest AC, Collas P. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 2005;16(12):5719–5735. [PubMed: 16195347]
94. Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y, et al. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett 2009;583(6):1029–1033. [PubMed: 19250937]
95. Tsunoda Y, Kato Y. [Animal cloning by somatic nuclear transfer]. Tanpakushitsu Kakusan Koso 2000;45(13 Suppl):2015–2020. [PubMed: 11021198]
96. Tweedell KS. New paths to pluripotent stem cells. Curr Stem Cell Res Ther 2008;3(3):151–162. [PubMed: 18781999]
97. Wade PA, Kikyo N. Chromatin remodeling in nuclear cloning. Eur J Biochem 2002;269(9):2284– 2287. [PubMed: 11985609]
98. Wakayama T, Shinkai Y, Tamashiro KL, Niida H, Blanchard DC, Blanchard RJ, et al. Cloning of mice to six generations. Nature 2000;407(6802):318–319. [PubMed: 11014179]
99. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 2008;26(8):916–924. [PubMed: 18594521]
100. Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2(1):10–12. [PubMed: 18371415]
101. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448(7151):318–324. [PubMed: 17554336]
102. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 1997;385(6619):810–813. [PubMed: 9039911]
103. Wilmut I, Young L, Campbell KH. Embryonic and somatic cell cloning. Reprod Fertil Dev 1998;10(7-8):639–643. [PubMed: 10612470]
104. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009 105. Yamanaka S. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci 2008;363(1500):2079–2087. [PubMed: 18375377]
106. Yan X, Qin H, Qu C, Tuan RS, Shi S, Huang GT. iPS cells reprogrammed from mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev. 2009
107. Yang X, Smith SL, Tian XC, Lewin HA, Renard JP, Wakayama T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet 2007;39(3):295–302. [PubMed: 17325680]
108. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002;416(6880):545–548. [PubMed: 11932748]
109. Yu J, Vodyanik MA, He P, Slukvin II, Thomson JA. Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 2006;24(1):168–176. [PubMed: 16210403]
